Eureka Genomics Lands a NIFA Award for $100,000
News Jun 28, 2012
The National Institute of Food and Agriculture (NIFA), USDA issued a $100,000 award for the development of Bovine Parentage Genotyping by Highly Multiplex Next Generation Sequencing.
This project is related to a Cooperative Research and Development Agreement (CRADA) between Eureka Genomics and the Agricultural Research Service, USDA to develop a low cost, low-density marker assay (LDMA) focused on the bovine industry.
The core technology for low cost high-throughput genotyping will have applications across animal, plant and clinical markets.
"The collaboration has resulted in a very cost-effective, high-throughput approach to single nucleotide polymorphism (SNP) genotyping, which is currently available for bovine parentage testing as well as for custom applications. Continuing development efforts are focused on increasing the number of SNPs that can be included in an assay, on further reducing the costs of adding SNP to assays, and on expanding the approach to include additional types of polymorphisms," said Mark Thallman, Ph.D. Research Geneticist and co-inventor of the technology, at the U.S. Meat Animal Research Center.
"The success of and knowledge created during the collaboration between Eureka Genomics and the USDA on LDMA for high-throughput genotyping is being leveraged into an ongoing collaboration between Eureka Genomics and the USDA that has expanded to include many diverse areas including 16S characterization and improved sample handling for next generation sequencing. Eureka Genomics is very pleased to continue to work with the U.S. Meat Animal Research Center to improve the applications of high throughput sequence data in the agricultural setting," said Heather Koshinsky, PhD., CSO, Eureka Genomics.
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018